Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Colonic Neoplasms × avelumab × 1 year × Clear all

Sponsor

Conditions

Carcinoma, Transitional Cell 13 Urinary Bladder Neoplasms 12 Neoplasms 8 Carcinoma, Renal Cell 8 Carcinoma, Merkel Cell 8 Neoplasm Metastasis 7 Breast Neoplasms 7 Squamous Cell Carcinoma of Head and Neck 6 Triple Negative Breast Neoplasms 4 Stomach Neoplasms 4 Ovarian Neoplasms 4 Melanoma 4 Carcinoma, Non-Small-Cell Lung 4 Uterine Cervical Neoplasms 3 Ureteral Neoplasms 3 Skin Neoplasms 3 Prostatic Neoplasms 3 Colorectal Neoplasms 3 Urethral Neoplasms 2 Small Cell Lung Carcinoma 2 Sarcoma 2 Head and Neck Neoplasms 2 Endometrial Neoplasms 2 Carcinoma, Hepatocellular 2 Urothelial Cancer 1 Turcot syndrome 1 Thymoma 1 Peritoneal Neoplasms 1 Penile Squamous Cell Carcinoma (PSCC) 1 Penile Neoplasms 1

Interventions

Oxaliplatin 29 Leucovorin 25 Fluorouracil 25 Bevacizumab 21 Cetuximab 20 Irinotecan 16 Capecitabine 15 Nivolumab 14 pembrolizumab 11 Folfox protocol 9 Magnetic Resonance Spectroscopy 8 Specimen Handling 7 Blood Specimen Collection 7 trifluridine tipiracil drug combination 6 encorafenib 6 Ipilimumab 6 regorafenib 5 fludarabine 5 Saline Solution 5 Immune Checkpoint Inhibitors 5 Gemcitabine 5 Exercise 5 Cyclophosphamide 5 Cisplatin 5 tislelizumab 4 dostarlimab 4 dehydroftorafur 4 cemiplimab 4 atezolizumab 4 Watchful Waiting 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡